Metabolism - Clinical and Experimental
Volume 45, Issue 10 , Pages 1221-1229, October 1996

Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension☆

  • Arvo Haenni

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Arvo Haenni, MD, Department of Geriatrics, PO Box 609, S-751 25 Uppsala, Sweden.
    • ,
  • Hans Lithell

Department of Geriatrics, Uppsala University, Uppsala, Sweden

Received 21 October 1995; accepted 25 April 1996.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by the Swedish Medical Research Council (project no. 5446), the Swedish National Association Against Heart and Lung Diseases, the Swedish Diabetic Society, and Laboratories Byk France.

PII: S0026-0495(96)90239-5

Metabolism - Clinical and Experimental
Volume 45, Issue 10 , Pages 1221-1229, October 1996

Article Tools